Biden Supports Temporary Waiver of COVID-19 Vaccine Patents

Focus on Closing Vaccine Vaccination Gaps by Country, Suggests Report

[Asia Economy New York=Correspondent Baek Jong-min] The U.S. government has officially announced its support for a temporary waiver of patents on COVID-19 vaccines. Analysts say that the ongoing discussions on suspending COVID-19 vaccine patents at the World Trade Organization (WTO) have reached a critical turning point.

Katherine Tai, U.S. Trade Representative (USTR), stated in a press release on the 5th (local time), "The U.S. government strongly supports intellectual property (IP) protection, but supports suspending patent rights on COVID-19 vaccines to end the pandemic."

[Image source=Reuters Yonhap News]

Representative Tai added, "The Biden administration's goal is to provide safe and effective vaccines to as many people as possible as quickly as possible," and said, "With vaccine supply secured for the American people, we will work with as many partners as possible to expand vaccine manufacturing and distribution."

President Biden also responded "yes" when asked whether the U.S. would support the WTO's waiver of intellectual property rights on COVID-19 vaccines.

The remarks by President Biden and Representative Tai are interpreted as the U.S. government deciding to support a temporary suspension of patents to address the vaccination gap between developed and developing countries, rather than focusing solely on expanding domestic vaccine production.

Until now, progressive groups and intellectuals in the U.S. have pressured for sharing vaccines with other countries to end the global COVID-19 pandemic. The WTO is scheduled to discuss the waiver of vaccine intellectual property rights following proposals from India and the Republic of South Africa.

This content was produced with the assistance of AI translation services.